(Updated - February 10, 2020 6:34 AM EST)(updated to add analyst comments)Cantor Fitzgerald analyst Alethia Young upgraded Adverum Biotechnologies (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Upgrades Upgrades

Adverum Biotechnologies (ADVM) Highlights New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDFebruary 10, 2020 5:57 AM